We are live on
!
Find out more
ACM
AIHC Capital Management Portfolio holdings
AUM
$120M
This Fund
S&P 500
This Quarter
Est. Return
+58.21%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
–
Cap. Flow
+$93.3M
Cap. Flow
% of AUM
87.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Revolution Medicines
RVMD
|
+$59M |
| 2 |
Protagonist Therapeutics
PTGX
|
+$15.5M |
| 3 |
ArriVent BioPharma
AVBP
|
+$13.4M |
| 4 |
Cogent Biosciences
COGT
|
+$2.81M |
| 5 |
NBP
NovaBridge Biosciences American Depositary Shares
NBP
|
+$1.83M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$39.3B
| $71.7M | 67.21% |
+900,392
| New | +$59M |
|
|
2
Protagonist Therapeutics
PTGX
$8.31B
| $16.6M | 15.54% |
+189,823
| New | +$15.5M |
|
|
3
ArriVent BioPharma
AVBP
$1.52B
| $13M | 12.16% |
+644,788
| New | +$13.4M |
|
|
4
Cogent Biosciences
COGT
$6.58B
| $3.55M | 3.33% |
+100,000
| New | +$2.81M |
|
|
NBP
5
NovaBridge Biosciences American Depositary Shares
NBP
$213M
| $1.65M | 1.54% |
+413,979
| New | +$1.83M |
|
6
Korro Bio
KRRO
$189M
| $242K | 0.23% |
+30,265
| New | +$707K |
|
Similar funds
WAG
DG
SA
AA
CM
CC
YMRC
BAM